布地格福联合金水宝胶囊治疗慢性阻塞性肺疾病的疗效观察  

Observation on the Curative Effect of Budesonide,Glycopyrronium Bromide and Formoterol Fumarate Combined with Jinshuibao Capsule in the Treatment of Chronic Obstructive Pulmonary Disease

作　　者：程靖 CHENG Jing(Department of Respiratory and Critical Care Medicine,Yiyang County People's Hospital,Yiyang 334400,Jiangxi,China)

机构地区：[1]弋阳县人民医院呼吸与危重症医学科,江西弋阳334400

出　　处：《医学信息》2025年第4期136-139,共4页Journal of Medical Information

摘　　要：目的研究金水宝胶囊与布地格福联用对慢性阻塞性肺疾病患者临床疗效的影响。方法选取2021年5月-2023年10月弋阳县人民医院收治的68例慢性阻塞性肺疾病患者作为研究对象,将所有患者按照随机数字表法分成对照组34例和研究组34例。对照组以布地格福治疗,研究组在其基础上联合金水宝胶囊治疗。比较两组治疗效果、肺功能、肺容量、6MWT及不良反应发生率。结果研究组总有效率高于对照组(P<0.05);研究组治疗后肺功能评分优于对照组(P<0.05);研究组肺容量优于对照组(P<0.05);研究组6MWT大于对照组(P<0.05);研究组不良反应发生率低于对照组(P<0.05)。结论在慢性阻塞性肺疾病治疗中,布地格福与金水宝胶囊合用疗效良好,可提高患者的肺功能、运动耐力和肺容量,是一种安全有效的治疗手段,值得临床应用。Objective To study the clinical effect of Jinshuibao capsule combined with budesonide,glycopyrronium bromide and formoterol fumarate on patients with chronic obstructive pulmonary disease.Methods By using the random number table method A total of 68 patients with chronic obstructive pulmonary disease admitted to Yiyang County People's Hospital from May 2021 to October 2023 were selected as the research objects,and they were divided into control group(34 patients)and study group(34 patients).The control group was treated with budesonide,glycopyrronium bromide and formoterol fumarate,and the study group was treated with Jinshuibao capsule on the basis of the control group.The therapeutic effect,lung function,lung volume,6MWT and incidence of adverse reactions were compared between the two groups.Results The study group had higher total effective rate than that of the control group(P<0.05).After treatment,the study group had better lung function score than that of the control group(P<0.05).The study group had better lung capacity than that of the control group(P<0.05).The study group had greater 6MWT than that of the control group(P<0.05).The study group had lower incidence of adverse reactions than that in the control group(P<0.05).Conclusion The combination of budesonide,glycopyrronium bromide and formoterol fumarate with Jinshuibao capsule has obvious curative effect on chronic obstructive pulmonary disease,which can improve the lung function,exercise endurance and lung capacity of patients.It is a safe and effective treatment method and is worthy of clinical application.

关 键 词：布地格福 金水宝胶囊 慢性阻塞性肺疾病 

分 类 号：R563[医药卫生—呼吸系统]